T1	HMM 382 426	safety, tolerability, and antiviral activity
T2	HMM 1554 1596	frequency of infection and viral shedding;
T3	HMM 1742 1750	infected
T4	HMM 2029 2061	viral titer area under the curve
T5	HMM 2293 2332	median (IQR) duration of viral shedding
T6	HMM 2443 2457	symptom scores
T7	HMM 2530 2568	nasal proinflammatory cytokine levels.
T8	HMM 2579 2602	mild to moderate nausea
